Next »
Transplantation Proceedings
Volume 36, Issue 10
, Pages 3234-3238
, December 2004
Cicloral versus neoral: A bioequivalence study in healthy volunteers on the influence of a fat-rich meal on the bioavailability of cicloral
References
- Drug, meal and formulation interactions influencing drug absorption after oral administration (Clinical implications) . Clin Pharmacokinet . 1999;36:233
- Use of cytotoxic agents and cyclosporine in the treatment of autoimmune disease (Part 1: rheumatologic and renal diseases) . Ann Intern Med . 1998;128:1021
- Use of cytotoxic agents and cyclosporine in the treatment of autoimmune disease (Part 2: inflammatory bowel disease, systemic vasculitis, and therapeutic toxicity) . Ann Intern Med . 1998;129:49
- . Clinical pharmacokinetics of cyclosporin . Clin Pharmacokinet . 1986;11:107
- Effect of food on the pharmacokinetics of cyclosporine in healthy subjects following oral and intravenous administration . J Clin Pharmacol . 1990;30:643
- Influence of a fat-rich meal on the pharmacokinetics of cyclosporine in a crossover comparison with the market formulation . Pharm Res . 1994;11:151
- . Cyclosporine microemulsion formulation (Neoral) in transplantation: pharmacokinetic/pharmacodynamic relationships . Transplant Proc . 1998;30:1694
-
Comparison of bioavailability and metabolism with two commercial formulations of cyclosporine A in rats
.
Drug Metab Dis
. 2002;30:658
-
FDA, Guidance for Industry: Food-Effect Bioavailability and Fed Bioequivalence Studies, Dec 2002. Available at: http://www.fda.gopv/cder/guidance/5194fnl.pdf
-
High-performance liquid chromatographic method for therapeutic drug monitoring of cyclosporine A and its two metabolites in renal transplant patients
.
J Chromatogr B
. 2000;749:93
-
Note for Guidance on the Investigation of Bioavailability and Bioequivalence, Committee for Proprietary Medicinal Products: Commission of the European Communities, London, England, July, 26, 2001
-
.
International harmonization on regulatory bioequivalence requirements
.
Clin Res Reg Affairs.
. 1993;10:203
- Pharmacokinetic cyclosporine A profiles under long-term Neoral treatment in renal transplant recipients: does fat intake still matter? . Transplant Proc . 1997;29:3137
- Comparison of peak and trough level monitoring of cyclosporine treatment using two modern cyclosporine preparations . Transplant Proc . 2003;35:1304
- . Influence of food on the bioavailability of drugs . Clin Pharmacokinet . 1978;3:337
- . Alternative cyclosporine metabolic pathways and toxicity . Clin Biochem . 1995;28:547
-
.
Cyclosporin clinical pharmacokinetics
.
Clin Pharmacokinetics
. 1993;24:472
-
.
Performance and specificity of monoclonal immunoassays for cyclosporine monitoring: how specific is specific?
.
Clin Chem
. 1999;45:37
- . Development of Sang-35: a cyclosporine formulation bioequivalent to Neoral . Clin Transplant . 1998;12:518
-
Bioequivalence study of Cipol-N (cyclosporine microemulsion preparation) in healthy adults. Transplant Proc
. 1998;30:3541
PII: S0041-1345(04)01184-4
doi: 10.1016/j.transproceed.2004.10.018
© 2004 Elsevier Inc. All rights reserved.
Next »
Transplantation Proceedings
Volume 36, Issue 10
, Pages 3234-3238
, December 2004
